Detalhe da pesquisa
1.
Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
Dig Dis Sci
; 67(11): 5272-5279, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091842
2.
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1-6 in Brazil.
Ann Hepatol
; 20: 100257, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949786
3.
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease.
Ann Hepatol
; 19(6): 674-690, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031970
4.
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.
Ann Hepatol
; 18(6): 849-854, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537509
5.
Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C.
Ann Hepatol
; 15(3): 326-32, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27049486
6.
Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma.
Ann Hepatol
; 13 Suppl 1: S4-40, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24998696
7.
Validation of the Brazilian version of Chronic Liver Disease Questionnaire.
Qual Life Res
; 22(1): 167-72, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22388695
8.
BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA.
Arq Gastroenterol
; 60(1): 106-131, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194769
9.
Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial.
Ann Hepatol
; 11(1): 52-61, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22166561
10.
OBSTRUCTIVE SLEEP APNEA SYNDROME RISK IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH OBESITY AND PRESENCE OF NASH.
Arq Gastroenterol
; 59(2): 251-256, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830037
11.
IS HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE >2.5 A DISTINGUISHED CRITERIA FOR METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IDENTIFICATION?
Arq Gastroenterol
; 59(3): 402-407, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102439
12.
Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
PLoS One
; 17(4): e0266505, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385529
13.
Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile.
Ann Hepatol
; 10(1): 33-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21301007
14.
Factors associated with nutritional status in liver transplant patients who survived the first year after transplantation.
J Gastroenterol Hepatol
; 25(2): 391-6, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19929929
15.
Evaluation of hepatic fibrosis by elastography in patients with schistosomiasis mansoni.
Trans R Soc Trop Med Hyg
; 114(7): 531-537, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32484861
16.
PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS.
Arq Gastroenterol
; 57(4): 471-476, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33331479
17.
The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study.
Am J Prev Cardiol
; 4: 100097, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34327473
18.
Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
J Gastroenterol Hepatol
; 24(9): 1541-6, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19743998
19.
Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.
Ann Hepatol
; 13 Suppl 2: s4-66, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25185535
20.
N-ACETYLCYSTEINE AND/OR URSODEOXYCHOLIC ACID ASSOCIATED WITH METFORMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL MULTICENTER RANDOMIZED CONTROLLED TRIAL.
Arq Gastroenterol
; 56(2): 184-190, 2019 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31460584